Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-1/Cisplatin Chemoradiotherapy for Resectable Esophageal Cancer
NCT00659113Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in esophageal cancer, sponsored by Yonsei University. Status: unknown.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00659113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659113.